Cape Investment Advisory’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$98.3K Sell
4,979
-531
-10% -$13.3K 0.03% 354
2026
Q2
$158K Buy
+5,510
New +$175K 0.04% 271
2026
Q1
– Sell
-3,154
Closed -$92.9K – 989
2025
Q4
$92.9K Buy
3,154
+536
+20% +$14.9K 0.03% 316
2025
Q3
$66.1K Buy
2,618
+38
+1% +$926 0.07% 195
2025
Q2
$61.9K Buy
2,580
+61
+2% +$1.41K 0.02% 340
2025
Q1
$57.7K Buy
2,519
+1,014
+67% +$24.5K 0.02% 320
2024
Q4
$38.1K Buy
1,505
+594
+65% +$15.1K 0.01% 367
2024
Q3
$22.7K Buy
911
+229
+34% +$6.78K 0.01% 437
2024
Q2
$20.2K Sell
682
-60
-8% -$1.66K 0.01% 421
2024
Q1
$22.4K Buy
+742
New +$20.6K 0.01% 427

Other funds holding RTO

Cape Investment Advisory's RTO Position: Q3 2026 in Review

Cape Investment Advisory reduced its Rentokil (RTO) stake by 9.6% in Q3 2026, selling an estimated $13.3K and leaving 4,979 shares worth $98.3K. The position accounts for 0.03% of the portfolio, ranked #354.

Cape Investment Advisory first reported a position in RTO in Q1 2024 and has held it in 10 quarters since. The position peaked at $158K in Q2 2026. 16 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Cape Investment Advisory held 4,979 shares of Rentokil worth $98.3K as of Q3 2026.
  • Cape Investment Advisory sold 531 Rentokil shares in Q3 2026, an estimated $13.3K.
  • Rentokil made up 0.03% of Cape Investment Advisory's portfolio in Q3 2026, its #354 holding.
  • Cape Investment Advisory first reported a position in Rentokil in Q1 2024 and has held it in 10 quarters since.
  • Cape Investment Advisory's Rentokil position peaked at $158K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Cape Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.